Related Experiment Videos
Rh phenotype prediction by DNA typing and its application to practice
W A Flegel1, F F Wagner, T H Müller
1Abteilung Transfusionsmedizin, Universitätsklinikum Ulm, Germany. waf@ucsd.edu
Transfusion Medicine (Oxford, England)
|January 9, 1999
Summary
Rh blood group DNA typing offers a molecular approach to predict phenotypes, improving upon traditional methods. This review details current DNA typing strategies for Rh factor prediction and their potential clinical applications.
Area of Science:
- Genetics
- Immunology
- Transfusion Medicine
Background:
- The RHD and RHCE genes present significant complexity, challenging molecular analysis of the Rh blood group system.
- DNA typing for Rh phenotypes, introduced in 1993, has been applied to prenatal testing and screening for partial D antigens.
- Current molecular methods face challenges in routine application due to complexity and cost.
Purpose of the Study:
- To review and summarize current knowledge on Rh phenotype prediction using DNA typing.
- To discuss the applications and limitations of these molecular techniques beyond research settings.
- To propose strategies for improving the reliability and cost-effectiveness of blood group genotyping.
Main Methods:
- Review of published literature on Rh DNA typing techniques, including PCR-SSP for polymorphism analysis.
- Detailed examination of procedures, results, and encountered problems in Rh genotyping.
- Analysis of Rh phenotype databases for developing and validating genotyping strategies.
Main Results:
- DNA typing for Rh phenotypes is a viable alternative to serological methods, particularly for complex cases like partial D.
- Analysis of multiple polymorphisms is recommended for accurate Rh DNA typing.
- Existing phenotype databases are crucial for refining genotyping strategies.
Conclusions:
- Rh DNA typing offers a powerful tool for Rh phenotype prediction, with potential to replace serological methods in routine transfusion medicine.
- A piecemeal approach to genotyping can enhance reliability and cost-efficiency.
- Further development is needed to fully integrate DNA typing into standard clinical practice.